Human reproduction
-
Clinical Trial
In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.
In vitro oocyte maturation (IVM) permits the use of immature oocytes in IVF. IVM does not require ovarian stimulation and so can be offered to patients at risk of ovarian hyperstimulation syndrome. ⋯ Our results show that IVM may be offered as an alternative to conventional IVF and to ovarian drilling in women with PCOS. The role of IVM in the therapeutic armamentarium for this condition should be further clarified.